ORD
Ordell Minerals Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 145.58%
Growth
10 months capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Ordell Minerals Ltd. engages in the metals business. The company is headquartered in Perth, Western Australia. The company went IPO on 2024-07-19. The firm has a prospective gold and lithium exploration portfolio, which includes three principal mineral assets: the Barimaia Joint Venture (JV) Project, the Goodia Project and the Fisher South Project located in the Yilgarn Craton of Western Australia (WA), Australia. The combined properties cover approximately 308 square kilometers (km2). The Barimaia JV Project comprises one mining lease, one exploration lease and 14 prospecting licenses in the Youanmi Terrane of the Yilgarn Craton near Mt Magnet. The Goodia Project is located within the eastern Goldfields region of WA and has the potential to host economic gold, nickel or lithium deposits. The project comprises one tenement E63/2313 and covers approximately 75km2. The Fisher South Project is located in the north-eastern Goldfields of WA, approximately 430km north of Kalgoorlie and comprises one tenement E53/2143, covering an area of 62 blocks (190km2).
📈 Performance
Price History
+121.43%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.47
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ORD
3
📊 Total Capital Earnings
$3K
🔃 Average investment frequency
9 weeks
💵 Average investment amount
$2,498
⏰ Last time a customer invested in ORD
27 days
ORD investor breakdown
💵 Income of investors
More than 200k
150k - 200k
33%
100k - 150k
67%
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
67%
35 - 90
33%
🙋 Legal gender of investors
Female
33%
Male
67%
Pearlers who invest in ORD also invest in...
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. The company is headquartered in Melbourne, Victoria. The company went IPO on 2005-02-03. The firm is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The firm has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.
🙌 Performance (5Yr p.a)
137.02%
📊 Share price
$13.19 AUD
📦 LOGISTICS
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
9.17%
📊 Share price
$103.06 AUD
🧱 MATERIALS
⛳️ DIVERSIFIED
💸 FINANCIALS
🇦🇺 AUSTRALIA
📈 HIGH PRICE GROWTH
VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
9.63%
📊 Share price
$100.76 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
20.57%
📊 Share price
$61.41 AUD
📈 HIGH PRICE GROWTH
💰 HIGH DIVIDEND
🇺🇸 UNITED STATES
IXI.AX was created on 2006-09-12 by iShares. The fund's investment portfolio concentrates primarily on consumer staples equity. The fund aims to provide investors with the performance of the S&P Global 1200 Consumer Staples Sector Index, before fees and expenses. The index is designed to measure the performance of global consumer staples companies and may include large-, mid- or smallcapitalisation stocks.
🙌 Performance (5Yr p.a)
5.91%
📊 Share price
$101.03 AUD
🌏 GLOBAL
Want more shares? Try these...
